GBLX News Alert Growblox Sciences Inc. (GBLX) 0.3099 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 1:21 PM

Growblox Sciences Inc. (GBLX) 0.3099 $GBLX

117 Marijuana Stocks For Your Do Not 'Buy-And-Hold' List
Anthony Cataldo - at Seeking Alpha - Fri Feb 06, 10:14AM CST

GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03)

GrowBLOX Signs License Agreement Including Initial Royalty Payment of $300,000 on its New Technology for the Consistent Production of Medical Cannabis
ACCESSWIRE - Wed Feb 04, 7:53AM CST
Las Vegas, NV / ACCESSWIRE / February 4, 2015 / GrowBLOX Sciences, Inc., "GB Sciences" (GBLX), a biopharmaceutical research and development company with state-of-the-art technologies in plant biology and cultivation, which are designed to produce consistent medicinal cannabis, has signed an agreement to license certain of its proprietary TissueBLOX technology to an unaffiliated licensed cannabis testing company. The licensed technology consists of certain equipment, procedures, and know-how related to the seedless propagation of genetically-identified strains of cannabis. The technology will enable the licensee to offer as a service to third-party growers the ability to grow specific strains of cannabis with an unprecedented level of reliability, precision, and most importantly, consistency of genetic material. As a practical matter what this means is that any grower, having developed and tested a strain of cannabis with certain characteristics desired by the grower, can provide for the continuous and consistent production of the genetics for that strain, enabling it to be branded as either a recreational or medicinal product.

99 Marijuana Stocks For Your Do Not 'Buy And Hold' List
Anthony Cataldo - at Seeking Alpha - Mon Feb 02, 6:25AM CST

GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03), ICN: 21.26 (-0.05)

Marijuana Firms - Exploring N=99, Ranked By Market Capitalization
Anthony Cataldo - at Seeking Alpha - Mon Feb 02, 3:34AM CST

GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03)

12 Marijuana Stocks For Your Do Not 'Buy And Hold' List - Part VIII
Anthony Cataldo - at Seeking Alpha - Wed Jan 28, 6:48AM CST

GWPH: 78.09 (+1.70), DE: 90.04 (+0.67), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03)

GrowBLOX Sciences Partners with Fuzhou Seechance Holding for Production of its Proprietary Growing Chambers
ACCESSWIRE - Mon Jan 12, 7:30AM CST
Untitled Document

GrowBLOX Sciences Executes Cannabis Supply Agreement with Provisionally Licensed Medical Cannabis Dispensary Facility
ACCESSWIRE - Wed Jan 07, 7:30AM CST
To Supply Medical Cannabis and Related Cannabis Products for Retail Sale; Retail Concessions for GB Sciences Nevada Brand-Name Products

GrowBLOX Sciences Provides Update on its Grow and Dispensary Efforts in Nevada
ACCESSWIRE - Wed Dec 17, 8:00AM CST
LAS VEGAS, NV / ACCESSWIRE / December 17, 2014 / GrowBLOX Sciences, Inc., "GB Sciences" (OTCQB:GBLX), a company that merges state-of-the-art technologies in plant biology, cultivation technology and post-production processes in order to optimize safe and consistent medicinal cannabis, is pleased to update its shareholders on its efforts to receive the necessary licenses to grow and dispense medical cannabis in Nevada.

GrowBLOX Sciences Provides Update on its Cultivation Plans in Las Vegas
ACCESSWIRE - Tue Dec 16, 1:14PM CST
Recently Received Nevada State Approval Targets a 1st Half 2015 Start-Up Date for Commercialization

GrowBLOX Sciences Appoints Cathryn Kennedy as CFO
GlobeNewswire - Tue Dec 09, 2:25PM CST
GrowBLOX Sciences, Inc. (OTCQB:GBLX), a company that focuses on plant biology and cultivation technology in order to optimize safe and consistent medical cannabis, today announced the appointment of Cathryn Kennedy as its Chief Financial Officer, effective immediately.

American Cannabis Company, A Delaware Corporation, Joins The List Of At Least 46 Other Marijuana Stocks
Anthony Cataldo - at Seeking Alpha - Sun Dec 07, 5:36PM CST

GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06)

Cannabis Legalization Wins Out in Midterm Elections
ACCESSWIRE - Mon Nov 10, 10:00AM CST
WHITEFISH, MT / ACCESSWIRE / November 10, 2014 / Cannabis stocks moved lower over the past week, according to data from the MarijuanaIndex(TM), despite favorable outcomes in the mid-term elections. Industry bellwethers, like GW Pharmaceuticals plc (NASDAQ: GWPH), traded largely sideways, although MedBox Inc. (OTC: MDBX) fell more than 20%.
GWPH: 78.09 (+1.70)

GB Sciences and NRC Research Institute Apply Crowdsourcing and Big Data Analytics to the Discovery and Validation of Cannabis-Based Therapies
GlobeNewswire - Mon Nov 10, 5:23AM CST
GrowBLOX Sciences, Inc., "GB Sciences" (OTCQB:GBLX), a company that merges state-of-the-art technologies in plant biology, cultivation technology and post-production processes in order to optimize safe and consistent medicinal cannabis, and NRC Research Institute ("NRC"

announce the joint development of a crowdsourcing application to discover cannabis-based therapeutic combinations that are effective in the treatment of serious disorders. The app uses real-time patient feedback, impairment testing, and biometric measurements to assess the efficacy of therapeutic products made with prescreened cannabis strains.

GB Sciences and MJ Freeway Collaborate on Cannabis Patient Care and Commerce App
GlobeNewswire - Fri Nov 07, 4:59AM CST
GrowBLOX Sciences, Inc., "GB Sciences" (OTCQB:GBLX), a company that merges state-of-the-art technologies in plant biology, cultivation technology and post-production processes in order to optimize our safe and consistent medicinal cannabis, has joined forces with cannabis industry enterprise software leader MJ Freeway to develop a breakthrough app which will enhance the medical cannabis patient experience. The free downloadable software will empower patients to register, make purchases, schedule pickup orders and--where available--request delivery of GB Sciences products.

GrowBLOX Sciences Receives Nevada State Approval for Cultivation of Cannabis-Based Therapies in Las Vegas
GlobeNewswire - Thu Nov 06, 5:30AM CST
GrowBLOX Sciences, Inc., ("GB Sciences"

(OTCQB:GBLX), announced today that its majority-controlled Nevada applicant, GB Sciences Nevada, LLC, has received Nevada State approval to proceed with its special use permit to establish and operate a medical marijuana cultivation facility in Clark County.

Cannabinoid Science Advancements Fuel Latest Clinical Trial Developments for Efficacy of CBD Therapies and Patents - Company Enters Stage 2 Of Trials for Cannabinoid Compounds
PR Newswire - Tue Nov 04, 7:15AM CST
Demand for cannaboid-CBD-based products rising in US as cannabis - medical marijuana movement continues forward. Sector being closely monitored as U.S. elections take place today. Cannabis Companies in focus today are: Earth Science Tech, Inc. (OTC: ETST), GW Pharmaceuticals plc (NASDAQ: GWPH), Growblox Sciences, Inc. (OTC: GBLX), Hemp, Inc. (OTC: HEMP) and Terra Tech Corp. (OTC: TRTC)
GWPH: 78.09 (+1.70)

GB Sciences Hosts First Medical Cannabis Conference in San Juan, Puerto Rico
GlobeNewswire - Mon Nov 03, 5:01AM CST
GB Sciences (OTCQB:GBLX), a company that merges state-of-the-art technologies in plant biology, cultivation technology and post-production processes in order to optimize safe and consistent medicinal cannabis, will host its first annual medical cannabis conference on November 14th.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Coventry's Jacobs Joins European Life Settlement Execs

Neal Jacobs Steps Up in Life Settlements Coventry has added another feather to its cap with Neal Jacobs, their Senior Managing Director of Capital Markets, joining the Executive Committee of the European Life Settlement Association (ELSA). Elected at ELSA's Annual General Meeting on September 15, 2026, Jacobs brings a wealth of experience that promises to bolster the...

New Data on SKYRIZI Offers Hope for Crohn's Patients

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Fluence Energy Faces Major Lawsuit Amid $3B Loss

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

Honeywell Aerospace Faces Legal Turbulence in Fraud Case

If you've got your chips on Honeywell Aerospace, Inc. (HONA), buckle up because things are getting choppy. Investors who took a bath on their shares now have the chance to put on their legal gloves and join a securities fraud class action lawsuit against the company. Legal Storm Over Misleading Statements Here's the rub: Between June 29 and September 1, 2026, the folks at...

Simple Home Upgrades That Boost Value Fast

Transform Your Home's Curb Appeal Without Breaking The Bank Every homeowner knows that feeling when you look at your house one day and think, "This could use a little something." Say you're strolling through a neighborhood in Fulton, N.Y., and notice a gem. It's not a brand new build, but it gleams with character. You bet it's had a few smart touches that could apply...

New American Funding Expands in Carolinas with Mullinix Move

The Gathering of Mortgage Titans You don't just waltz into the mortgage world with a $2 billion track record and expect folks not to notice. Will Mullinix, a name that's become synonymous in the Carolinas with mortgage mastery, has decided to bring his influential Mullinix Mortgage Group under the banner of New American Funding. Talk about a power play. This bold strategy...

Think Tank Pushes for Bold Parkinson's Prevention Plan

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Navigating Battery Compliance for AI Data Centers

Untangling the Web of Global Battery Compliance Amid clamor about AI's insatiable appetite for energy storage, the rules around shipping, installing, and handling data center batteries have become a tangled web. From Waxahachie, Texas, Americase International plans to take the stage at the OCP Global Summit on October 15, 2026, to spearhead a discussion on bridging the...

Paradigm Therapeutics: A Beacon in Rare Diseases

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

OmniActive's Fenavari: A New Era in Women's Health

Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...